ICCC
ImmuCell Corporation
10.00$
+0.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9,409.0% | – | 5.8% | 10.6% | -10.6% | 0.0% | 19.5% | 24.8% | -21.5% | 6.3% | 34.5% | 42.0% | 19.2% | |
| 12,890.5% | – | 9.2% | 12.3% | 11.2% | 8.8% | 8.4% | 10.4% | 12.3% | 9.3% | 5.1% | 6.5% | 7.8% | |
| 1,787.0% | – | 1.1% | 1.8% | 1.3% | 0.9% | 0.6% | 1.0% | 1.3% | 1.4% | 1.3% | 3.3% | 1.8% | |
| -8,157.1% | – | 1.9% | 24.8% | -11.0% | -15.9% | -7.2% | 6.2% | -30.1% | -2.8% | 9.1% | 6.3% | -1.6% | |
| 7,792.4% | 0.0% | 1.0% | 2.0% | 1.5% | 2.5% | 4.1% | 2.4% | 10.8% | 2.3% | 1.7% | 10.2% | 5.5% | |
| -9,881.6% | – | -1.0% | -1.9% | -1.5% | -2.5% | -4.1% | -2.0% | -10.8% | -2.2% | -1.6% | -10.2% | -5.4% | |
| – | – | – | – | -6.1% | -4.8% | -4.7% | -5.9% | -5.9% | -5.2% | -3.9% | -5.6% | -5.0% | |
| 29,207.2% | – | -5.1% | -2.0% | 53.4% | 1.9% | -5.0% | -1.2% | -6.1% | -5.2% | -3.9% | -3.3% | -4.5% | |
| 9,916.6% | – | -0.3% | 6.6% | 41.3% | -0.7% | 10.4% | 21.7% | -38.4% | -1.0% | 29.0% | 28.5% | 9.3% | |
| -17,201.3% | – | 4.8% | 8.6% | -12.1% | -2.6% | 15.4% | 22.4% | -32.3% | 4.1% | 32.8% | 31.8% | 13.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.